The two faces of the same medal… or maybe not? Comparing osteoarthritis and calcium pyrophosphate deposition disease: a laboratory and ultrasonographic study.


Journal

Clinical and experimental rheumatology
ISSN: 0392-856X
Titre abrégé: Clin Exp Rheumatol
Pays: Italy
ID NLM: 8308521

Informations de publication

Date de publication:
Historique:
received: 10 11 2019
accepted: 24 02 2020
pubmed: 18 4 2020
medline: 11 2 2021
entrez: 18 4 2020
Statut: ppublish

Résumé

Osteoarthritis (OA) and calcium pyrophosphate deposition disease (CPPD) are frequently associated but the real relation between these diseases is not still understood. The aim of this paper is to investigate the characteristics in terms of inflammation, anatomical changes and synovial fluid (SF) features in knees of patients with OA and CPPD. Consecutive patients older than 55 years with knee pain and swelling were enrolled. All patients underwent a complete clinical examination, a US examination of the affected joint, arthrocentesis of the knee and analysis of synovial fluid, including dosing of inorganic ions and number of crystals. The gold standard for the diagnosis was the microscopic analysis of the SF. Sixty-seven patients were enrolled, 25 affected by OA and 42 by CPPD. At US, a significantly higher amount of effusion and synovitis was identified in patients with CPPD but there were no significant differences regarding structural changes. At the SF analysis, the white blood cell (WBC) count was higher in patients with CPPD who also presented a higher number of polymorphonuclear cells and a lower number of monocytes. Regarding the inorganic ion concentration, the statistical analysis did not reveal any differences. The number of crystals in the SF, correlated with a larger effusion, higher grade of synovitis and a higher WBC count. A higher degree of inflammation was found in patients with CPPD. The findings suggest that longitudinal studies would be useful to better understand the evolution of the diseases and highlight the need for different treatment strategies.

Identifiants

pubmed: 32301428
pii: 14986
doi: 10.55563/clinexprheumatol/gu9j0q
doi:

Substances chimiques

Calcium Pyrophosphate X69NU20D19

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

66-72

Auteurs

Georgios Filippou (G)

Section of Rheumatology, Department of Medical Sciences, University of Ferrara, Italy. gf.filippou@gmail.com.

Anna Scanu (A)

Rheumatology Unit, Department of Medicine-DIMED, University of Padova, Italy.

Antonella Adinolfi (A)

Rheumatology Unit, Ospedale Metropolitano Niguarda, Milan, Italy.

Valentina Picerno (V)

Rheumatology Unit, Azienda Ospedaliera Regionale San Carlo, Potenza, Italy.

Carmela Toscano (C)

Rheumatology Section, Department of Medicine, Surgery and Neurosciences, University of Siena, Italy.

Alessandra Bortoluzzi (A)

Section of Rheumatology, Department of Medical Sciences, University of Ferrara, Italy.

Bruno Frediani (B)

Rheumatology Section, Department of Medicine, Surgery and Neurosciences, University of Siena, Italy.

Marcello Govoni (M)

Section of Rheumatology, Department of Medical Sciences, University of Ferrara, Italy.

Leonardo Punzi (L)

Centre for Gout and Metabolic Bone and Joint Diseases, Rheumatology, SS Giovanni and Paolo Hospital, Venice, Italy.

Carlo Alberto Scirè (CA)

Section of Rheumatology, Department of Medical Sciences, University of Ferrara, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH